![]() |
시장보고서
상품코드
1728386
세계의 헬스케어 분야 저온 플라즈마 시장 : 산업 규모, 점유율, 동향, 기회, 예측 - 용도별(창상 치유, 외과 용도, 기타 의료 용도), 지역별, 경쟁별(2020-2030년)Cold Plasma in Healthcare Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Wound Healing, Surgical Application and Other Medical Applications), By Region and Competition, 2020-2030F |
세계의 헬스케어 분야 저온 플라즈마 시장은 2024년에 21억 4,000만 달러로 평가되었고, 2030년에는 42억 5,000만 달러에 이를 것으로 예측되며, 예측 기간 동안 CAGR 12.11%로 성장할 전망입니다.
비열적, 비침습적인 이온화 가스 기술인 콜드 플라즈마는 상처 치유, 멸균, 암 치료, 피부과 치료 등 폭넓은 용도로 현대의 헬스케어에 변혁을 가져오고 있습니다. 건강한 조직에 손상을 주지 않으면서 병원체를 파괴하고 조직 재생을 촉진하며 혈관신생을 자극하는 그 능력은 귀중한 의료 도구가 되고 있습니다.
시장 개요 | |
---|---|
예측 기간 | 2026-2030년 |
시장 규모(2024년) | 21억 4,000만 달러 |
시장 규모(2030년) | 42억 5,000만 달러 |
CAGR(2025-2030년) | 12.11% |
급성장 부문 | 상처 치유 |
최대 시장 | 북미 |
특히 당뇨병이나 암 등 고도로 저침습적인 치료가 필요한 질환에 있어서 현저합니다. 콜드 플라즈마는 만성 창상 관리 및 감염 제어 지원에 있어 유망한 결과를 나타내고 있으며, 특히 팬데믹 후의 헬스케어 전략에 있어 매우 중요합니다. 게다가 공기중의 바이러스를 거의 순간에 불활성화하는 콜드 플라즈마의 가능성이 학술적 및 임상적으로 조사되어 호흡 요법에 대한 용도에 관심이 높아지고 있습니다. 이러한 개발은, 다양한 의료 현장에서, 신뢰성이 높고 혁신적인 치료 및 멸균 솔루션으로서 콜드 플라즈마 기술의 채용이 증가하고 있는 것을 증명하고 있습니다.
만성 질환 증가
헬스케어 워크플로우에 통합
데이터 중심의 헬스케어
The Global Cold Plasma in Healthcare Market was valued at USD 2.14 Billion in 2024 and is projected to reach USD 4.25 Billion by 2030, growing at a CAGR of 12.11% during the forecast period. Cold plasma, a non-thermal, non-invasive ionized gas technology, is transforming modern healthcare with its wide range of applications, including wound healing, sterilization, cancer therapy, and dermatological treatments. Its ability to destroy pathogens, promote tissue regeneration, and stimulate angiogenesis without damaging healthy tissue makes it a valuable medical tool.
Market Overview | |
---|---|
Forecast Period | 2026-2030 |
Market Size 2024 | USD 2.14 Billion |
Market Size 2030 | USD 4.25 Billion |
CAGR 2025-2030 | 12.11% |
Fastest Growing Segment | Wound Healing |
Largest Market | North America |
The market is gaining momentum as chronic disease prevalence rises globally, particularly in conditions like diabetes and cancer that require advanced, minimally invasive treatments. Cold plasma is showing promising results in managing chronic wounds and aiding infection control-especially crucial in post-pandemic healthcare strategies. Additionally, with academic and clinical research highlighting cold plasma's potential to inactivate airborne viruses almost instantly, interest has surged for respiratory therapy applications. These developments underscore the increasing adoption of cold plasma technology as a reliable, innovative therapeutic and sterilization solution across diverse medical settings.
Key Market Drivers
Increasing Chronic Diseases
The growing burden of chronic diseases such as cancer, diabetes, and cardiovascular disorders is a major factor driving demand for cold plasma technologies in healthcare. According to the World Health Organization, noncommunicable diseases (NCDs) accounted for over 43 million deaths in 2021, with a disproportionate impact in low- and middle-income countries.
Cold plasma has emerged as a promising treatment modality for addressing the complications arising from these conditions. For instance, in diabetic patients, chronic ulcers present a persistent challenge; cold plasma accelerates healing by enhancing tissue oxygenation and reducing microbial load. Similarly, its application in oncology helps target cancer cells while sparing healthy tissue, offering an advanced alternative to traditional therapies. As healthcare systems globally aim to manage rising NCDs with precision and minimal side effects, the role of cold plasma technologies is becoming increasingly significant.
Key Market Challenges
Integration into Healthcare Workflows
One of the critical challenges in the cold plasma healthcare market is integrating these advanced technologies into established clinical workflows. Many healthcare facilities operate within strict procedural frameworks and require seamless compatibility with existing medical infrastructure.
Adopting cold plasma devices involves not only purchasing equipment but also modifying infrastructure, allocating physical space, and ensuring adequate training for clinical staff. These adjustments may be resource-intensive and time-consuming, particularly in smaller hospitals or facilities in developing regions. Without smooth integration, the potential clinical benefits of cold plasma may be underutilized or delayed, hampering market expansion despite the technology's efficacy.
Key Market Trends
Data-Driven Healthcare
The shift toward data-driven healthcare is reshaping how cold plasma devices are utilized. The integration of smart sensors and real-time monitoring capabilities allows healthcare providers to collect treatment data-such as gas flow, temperature, and dosage metrics-during procedures.
These insights enhance treatment precision and improve outcomes. For instance, in wound care, real-time feedback helps clinicians adjust parameters on-the-fly to accelerate healing. In oncology, data analytics can optimize dosage delivery to ensure cancer cells are effectively targeted. The ability to personalize treatment protocols based on real-time patient data marks a critical step in aligning cold plasma technology with the broader movement toward precision medicine and connected healthcare systems.
In this report, the Cold Plasma in Healthcare Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Cold Plasma in Healthcare Market.
Cold Plasma in Healthcare Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: